Hye Jin An Selected Research

Inflammation (Inflammations)

1/2018	A PPAR Pan Agonist, MHY2013 Alleviates Age-Related Hepatic Lipid Accumulation by Promoting Fatty Acid Oxidation and Suppressing Inflammation.
10/2017	Thio-barbiturate-derived compounds are novel antioxidants to prevent LPS-induced inflammation in the liver.
7/2017	Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging.
7/2017	The critical role played by endotoxin-induced liver autophagy in the maintenance of lipid metabolism during sepsis.
1/2017	Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome.
9/2015	(2R/S,4R)-2-(2,4-Dihydroxyphenyl)thiazolidine-4-carboxylic acid prevents UV-induced wrinkle formation through inhibiting NF-κB-mediated inflammation.
8/2015	Age-related sensitivity to endotoxin-induced liver inflammation: Implication of inflammasome/IL-1β for steatohepatitis.
4/2014	Caffeic acid regulates LPS-induced NF-κB activation through NIK/IKK and c-Src/ERK signaling pathways in endothelial cells.
1/2014	Anti-wrinkle effect of magnesium lithospermate B from Salvia miltiorrhiza BUNGE: inhibition of MMPs via NF-kB signaling.
1/2013	Anti-wrinkle and anti-inflammatory effects of active garlic components and the inhibition of MMPs via NF-κB signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hye Jin An Research Topics

Disease

10	Inflammation (Inflammations) 01/2018 - 01/2013
6	Insulin Resistance 01/2018 - 03/2016
3	Body Weight (Weight, Body) 11/2022 - 01/2018
3	Fatty Liver 01/2018 - 08/2015
2	Neoplasms (Cancer) 11/2020 - 10/2017
2	Obesity 01/2018 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 03/2016
1	Adenocarcinoma of Lung 11/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Hyperpigmentation 10/2017
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2017
1	Sepsis (Septicemia) 07/2017
1	Weight Gain 01/2017
1	Hyperinsulinism (Hyperinsulinemia) 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2017

Drug/Important Bio-Agent (IBA)

5	LipidsIBA 01/2020 - 08/2015
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 03/2016
3	AntioxidantsIBA 10/2017 - 01/2013
2	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 10/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 07/2017
2	Insulin (Novolin)FDA Link 01/2018 - 01/2017
2	NF-kappa B (NF-kB)IBA 10/2017 - 01/2014
2	EndotoxinsIBA 07/2017 - 08/2015
2	propionic acid (potassium propionate)IBA 01/2017 - 03/2016
2	InflammasomesIBA 01/2017 - 08/2015
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2014 - 01/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014 - 01/2013
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 11/2022
1	fibroblast growth factor 21IBA 11/2022
1	Gefitinib (Iressa)FDA Link 11/2020
1	Pemetrexed (MTA)FDA Link 11/2020
1	Tyrosine Kinase InhibitorsIBA 11/2020
1	Oleic Acid (Oleate)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	AcidsIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	ResveratrolIBA 01/2018
1	SRT1720IBA 01/2018
1	Sirtuin 1IBA 01/2018
1	NAD (NADH)IBA 01/2018
1	barbituric acid (barbiturate)IBA 10/2017
1	Melanins (Melanin)IBA 10/2017
1	Monophenol Monooxygenase (Tyrosinase)IBA 10/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2017
1	Chloroquine (Aralen)FDA LinkGeneric 07/2017
1	Betaine (C.B.B.)FDA Link 01/2017
1	Hormones (Hormone)IBA 01/2017
1	Carboxylic AcidsIBA 09/2015
1	ThiazolidinesIBA 09/2015
1	Transcription Factors (Transcription Factor)IBA 04/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2013
1	caffeic acidIBA 01/2013
1	UracilIBA 01/2013
1	S-allylcysteine (allyl cysteine)IBA 01/2013

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 11/2020
1	Chemoradiotherapy 10/2017